These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33676843)

  • 1. Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis.
    Ishii T; Sasaki M; Yamada K; Kato D; Osuka H; Aoki K; Morita T; Ishii Y; Tateda K
    J Infect Chemother; 2021 Jun; 27(6):915-918. PubMed ID: 33676843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.
    Hirotsu Y; Maejima M; Shibusawa M; Nagakubo Y; Hosaka K; Amemiya K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Yagi S; Kojima S; Omata M
    Int J Infect Dis; 2020 Oct; 99():397-402. PubMed ID: 32800855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2.
    Kodana M; Orihara Y; Tezuka M; Takahashi R; Noguchi S; Matsuzaki N; Takada T; Kobari N; Ogane K; Kawamura R; Kawamura T; Takeuchi S; Kamiyama Y; Shiomi R; Aoyagi R; Saito M; Kusano T; Nakaya N; Kaneko S; Morita H; Uchida Y; Yazawa H; Sekiya R; Katayama K; Mikami S; Sato T; Tarumoto N; Kobayashi T; Nakamoto H; Maeda T
    J Infect Chemother; 2023 Jun; 29(6):586-591. PubMed ID: 36849098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2.
    Carrouel F; Valette M; Perrier H; Bouscambert-Duchamp M; Dussart C; Tramini P; Bourgeois D
    Viruses; 2021 May; 13(5):. PubMed ID: 34066046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples.
    Cassinari K; Alessandri-Gradt E; Chambon P; Charbonnier F; Gracias S; Beaussire L; Alexandre K; Sarafan-Vasseur N; Houdayer C; Etienne M; Caron F; Plantier JC; Frebourg T
    Clin Chem; 2021 Apr; 67(5):736-741. PubMed ID: 33331864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
    Basso D; Aita A; Padoan A; Cosma C; Navaglia F; Moz S; Contran N; Zambon CF; Maria Cattelan A; Plebani M
    Clin Chim Acta; 2021 Jun; 517():54-59. PubMed ID: 33626369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs.
    Dogan OA; Kose B; Agaoglu NB; Yildiz J; Alkurt G; Demirkol YK; Irvem A; Doganay GD; Doganay L
    J Virol Methods; 2021 Apr; 290():114049. PubMed ID: 33387561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review.
    Comber L; Walsh KA; Jordan K; O'Brien KK; Clyne B; Teljeur C; Drummond L; Carty PG; De Gascun CF; Smith SM; Harrington P; Ryan M; O'Neill M
    Rev Med Virol; 2021 Jul; 31(4):e2185. PubMed ID: 33091200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.
    Bastos ML; Perlman-Arrow S; Menzies D; Campbell JR
    Ann Intern Med; 2021 Apr; 174(4):501-510. PubMed ID: 33428446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity assay for detection of SARS-CoV-2 in samples from patients with COVID-19.
    Hiroi S; Kubota-Koketsu R; Sasaki T; Morikawa S; Motomura K; Nakayama EE; Okuno Y; Shioda T
    J Med Virol; 2021 Oct; 93(10):5917-5923. PubMed ID: 34139026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Kashiwagi K; Miyazaki T; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):319-322. PubMed ID: 33388232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2.
    Plantamura J; Bousquet A; Otto MP; Bigaillon C; Legland AM; Delacour H; Vest P; Astier H; Valero E; Bylicki O; Renard C; Martin S; Verret C; Garnotel E; Foissaud V; Mérens A; Janvier F
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2191-2198. PubMed ID: 33987804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.
    Courtellemont L; Guinard J; Guillaume C; Giaché S; Rzepecki V; Seve A; Gubavu C; Baud K; Le Helloco C; Cassuto GN; Pialoux G; Hocqueloux L; Prazuck T
    J Med Virol; 2021 May; 93(5):3152-3157. PubMed ID: 33615487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19.
    Stokes W; Berenger BM; Portnoy D; Scott B; Szelewicki J; Singh T; Venner AA; Turnbull L; Pabbaraju K; Shokoples S; Wong AA; Gill K; Guttridge T; Proctor D; Hu J; Tipples G
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1721-1726. PubMed ID: 33742322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.
    Johnson AJ; Zhou S; Hoops SL; Hillmann B; Schomaker M; Kincaid R; Daniel J; Beckman K; Gohl DM; Yohe S; Knights D; Nelson AC
    Microbiol Spectr; 2021 Sep; 9(1):e0008621. PubMed ID: 34259552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.